Protein Crystallography by Experimental Drug Development Centre (EDDC) |
 |
| SMYD3 structure solved by XRAY |
Understanding protein-ligand interactions is pivotal for accelerating lead identification and structure guided lead optimisation. Our team of experts at the X-ray crystallography (XRAY) platform support the determination of high-resolution structures of proteins and ligand binding conformations. The X-ray team provides a customised approach to your structural characterization studies starting from protein expression & purification to optimization of crystallization conditions to generate atomic resolution structures using commercial Beam line at Australian synchrotron & Japan Spring-8 synchrotron. |
Key Services |
|
|
|
 |
| EYA2 structure solved by XRAY |
 |
| PYCR structure solved by XRAY |
Key Capabilities |
|
|
|
|
|
Expertise in Diverse Targets |
|
|
|
|
|
|
|
|
 |
| EYA2 structure solved by XRAY |
 |
 |
Protein Structure & Biophysics consisting of Fragment Based Screening (FBS) and Protein crystallography (XRAY) is part of the EDDC Academic Research Organisation or EARO, a Fee-for-Service initiative by the Experimental Drug Development Centre (EDDC). Founded in 2020, EARO was conceived to provide greater access to EDDC’s rich scientific expertise and state of the art technology platforms to the academic and industry researchers in the biomedical ecosystem who aspire to embark on a journey of translating their research into drug candidates. EARO comprises primarily of 5 core drug discovery platforms headed by scientists with decades of experience. The EARO Platforms include High Throughput Screening (HTS), Fragment Based Screening (FBS), Protein Crystallography (XRAY), High Throughput Phenomics (HTP) and Computational Phenomics Platforms (CPP). Together, EARO groups have engaged with more than 70 academic and industry partners. |
| Visit https://www.earo.sg/ for more information or email enquiries@rsc.a-star.edu.sg |
 |
